Literature DB >> 3595796

Circadian fluctuation of susceptibility to haloperidol under constant conditions.

H Nagayama, A Takagi, R Takahashi.   

Abstract

An endogenous circadian rhythm of the sedative and antiapomorphine effects of haloperidol was observed under constant conditions for 7 days as well as under an entrained light-dark cycle.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3595796     DOI： 10.1007/bf02126357

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  7 in total

1.  Chromopharmacological study of neuroleptics. III. Circadian rhythm of brain susceptibility to haloperidol.

Authors:  H Nagayama; A Takagi; Y Sakurai; S Yoshimoto; K Nishiwaki; R Takahasi
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

2.  Day-night periodicity in pentobarbital response of mice and the influence of socio-psychological conditions.

Authors:  W M DAVIS
Journal:  Experientia       Date:  1962-05-15

3.  Circadian susceptibility rhythm to neuroleptics: tetrabenazine.

Authors:  H Nagayama; A Takagi; T Tateishi; R Takahashi
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

4.  A circadian susceptibility rhythm in rats to Pentobarbital Sodium.

Authors:  L E Scheving; D F Vedral; J E Pauly
Journal:  Anat Rec       Date:  1968-04

5.  Circadian susceptibility rhythm to apomorphine in the brain.

Authors:  H Nagayama; A Takagi; E Nakamura; H Yoshida; R Takahashi
Journal:  Commun Psychopharmacol       Date:  1978

6.  Chronopharmacological study of neuroleptics. II. Circadian susceptibility rhythm to chlorpromazine.

Authors:  H Nagayama; A Takagi; Y Sakurai; K Nishiwaki; R Takahashi
Journal:  Psychopharmacology (Berl)       Date:  1978-06-15       Impact factor: 4.530

7.  Circadian rhythms in drug action and drug metabolism in the mouse.

Authors:  T L Holcslaw; T S Miya; W S Bousquet
Journal:  J Pharmacol Exp Ther       Date:  1975-11       Impact factor: 4.030
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.